VERU-944 Therapy for Hot Flashes in Men Receiving Prostate Cancer Hormone Treatment Heads to Trial May 26, 2017 Veru Healthcare is set to begin a Phase 2 clinical trial evaluating VERU-944 (APP-944) for the treatment of hot flashes in men receiving hormone therapy for prostate cancer.Read more. Source: Prostate Cancer News Today Prostate Cancer News
Veru Healthcare is set to begin a Phase 2 clinical trial evaluating VERU-944 (APP-944) for the treatment of hot flashes in men receiving hormone therapy for prostate cancer.Read more. Source: Prostate Cancer News Today
